Finanzen von Universal Technical Institute Inc (UTI)UTIUniversal Technical Institute Inc

Universal Technical Institute, Inc. (UTI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is UTI, accounting for 64.5% of total sales, equivalent to $142.72M. Another important revenue stream is Concorde. Understanding this composition is critical for investors evaluating how UTI navigates market cycles within the Professional & Business Education industry.

Evaluating the bottom line, Universal Technical Institute, Inc. maintains a gross margin of 45.94%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 1.48%, while the net margin is 1.04%. These profitability ratios, combined with a Return on Equity (ROE) of 10.53%, provide a clear picture of how effectively UTI converts its operational activities into shareholder value.

In the context of the broader market, UTI competes directly with industry leaders such as CLVT and SLN. With a market capitalization of $1.14B, it holds a significant position in the sector. When comparing efficiency, UTI's gross margin of 45.94% stands against CLVT's 36.80% and SLN's 97.39%. Such benchmarking helps identify whether Universal Technical Institute, Inc. is trading at a premium or discount relative to its financial performance.

UTI reported a revenue of $218.907 million for Q3 2026, a 7.2% increase year-over-year, but net income significantly dropped to $2.279 million, down from $10.663 million the previous year. The gross margin has also decreased, with the latest figure at 45.94%.